IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical Hepatocarcinogenesis
暂无分享,去创建一个
Michael Karin | M. Karin | H. Leffert | S. Maeda | H. Kamata | Jun-Li Luo | Shin Maeda | Hideaki Kamata | Jun-Li Luo | Hyam Leffert
[1] Michael Karin,et al. Reactive Oxygen Species Promote TNFα-Induced Death and Sustained JNK Activation by Inhibiting MAP Kinase Phosphatases , 2005, Cell.
[2] H. Schreiber,et al. Inflammation as a tumor promoter in cancer induction. , 2004, Seminars in cancer biology.
[3] Josepa Ribes,et al. Primary liver cancer: worldwide incidence and trends. , 2004, Gastroenterology.
[4] S. Thorgeirsson,et al. Regulation of α-Fetoprotein by Nuclear Factor-κB Protects Hepatocytes from Tumor Necrosis Factor-α Cytotoxicity during Fetal Liver Development and Hepatic Oncogenesis , 2004, Cancer Research.
[5] Y. Ben-Neriah,et al. NF-κB functions as a tumour promoter in inflammation-associated cancer , 2004, Nature.
[6] Michael Karin,et al. IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer , 2004, Cell.
[7] J. T. Saari,et al. Abrogation of Nuclear Factor-κB Activation Is Involved in Zinc Inhibition of Lipopolysaccharide-Induced Tumor Necrosis Factor-α Production and Liver Injury , 2004 .
[8] A. Datta,et al. Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. , 2004, Genes & development.
[9] M. Karin,et al. The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4 , 2004, Nature.
[10] Masayuki Yamamoto,et al. Unique function of the Nrf2-Keap1 pathway in the inducible expression of antioxidant and detoxifying enzymes. , 2004, Methods in enzymology.
[11] S. Thorgeirsson,et al. Regulation of alpha-fetoprotein by nuclear factor-kappaB protects hepatocytes from tumor necrosis factor-alpha cytotoxicity during fetal liver development and hepatic oncogenesis. , 2004, Cancer research.
[12] Jennifer Y. Zhang,et al. NF-kappaB RelA opposes epidermal proliferation driven by TNFR1 and JNK. , 2004, Genes & development.
[13] Michael Karin,et al. The IKK NF-κB system: a treasure trove for drug development , 2004, Nature Reviews Drug Discovery.
[14] M. Karin,et al. IKKβ Is Required for Prevention of Apoptosis Mediated by Cell-Bound but Not by Circulating TNFα , 2003 .
[15] Takahiro Doi,et al. NF‐κB inhibits TNF‐induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death , 2003, The EMBO journal.
[16] Jennifer Y. Zhang,et al. NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia , 2003, Nature.
[17] E. Wagner,et al. Liver Tumor Development c-Jun Antagonizes the Proapoptotic Activity of p53 , 2003, Cell.
[18] S. Thorgeirsson,et al. Molecular pathogenesis of human hepatocellular carcinoma , 2002, Nature Genetics.
[19] T. Misteli,et al. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.
[20] R. Pierce,et al. Bcl-2 expression inhibits liver carcinogenesis and delays the development of proliferating foci. , 2002, The American journal of pathology.
[21] Michael Karin,et al. NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.
[22] M. Karin,et al. Missing Pieces in the NF-κB Puzzle , 2002, Cell.
[23] M. Mori,et al. Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine , 2002, Oncogene.
[24] M. Hayakari,et al. Nrf2 transactivator-independent GSTP1-1 expression in "GSTP1-1 positive" single cells inducible in female mouse liver by DEN: a preneoplastic character of possible initiated cells. , 2002, Carcinogenesis.
[25] M. Karin,et al. Inhibition of JNK activation through NF-κB target genes , 2001, Nature.
[26] S. Thorgeirsson,et al. Heterozygous mice for the transforming growth factor-beta type II receptor gene have increased susceptibility to hepatocellular carcinogenesis. , 2001, Cancer research.
[27] Y. Liaw,et al. Constitutive activation of nuclear factor κB in hepatocellular carcinoma , 2000 .
[28] S. Thorgeirsson,et al. Transgenic mouse models in carcinogenesis research and testing. , 2000, Toxicology letters.
[29] S. Thorgeirsson,et al. Vitamin E reduces chromosomal damage and inhibits hepatic tumor formation in a transgenic mouse model. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[30] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[31] A. Hara,et al. Effects of Fas-mediated liver cell apoptosis on diethylnitrosamine-induced hepatocarcinogenesis in mice , 2000, British Journal of Cancer.
[32] N. Fausto. Liver regeneration. , 2000, Journal of hepatology.
[33] Inder M. Verma,et al. Severe Liver Degeneration in Mice Lacking the IκB Kinase 2 Gene , 1999 .
[34] N. Fausto,et al. Mouse Liver Tumorigenesis: Models, Mechanisms, and Relevance to Human Disease , 1999, Seminars in liver disease.
[35] M. Kay,et al. The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors , 1997, Journal of virology.
[36] J. Peschon,et al. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[37] G. Williams,et al. N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. , 1996, Pharmacology & therapeutics.
[38] F. Chisari. Hepatitis B virus transgenic mice: Insights into the virus and the disease , 1995, Hepatology.
[39] A. Groen,et al. Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis. , 1994, The American journal of pathology.
[40] U. Schibler,et al. The 5' flanking region of the rat LAP (C/EBP beta) gene can direct high-level, position-independent, copy number-dependent expression in multiple tissues in transgenic mice. , 1994, Nucleic acids research.
[41] Gary M Williams,et al. Inhibition of Chemical-Induced Experimental Cancer by Synthetic Phenolic Antioxidants , 1993, Toxicology and industrial health.
[42] P. Schirmacher,et al. The role of Ito cells in the biosynthesis of HGF-SF in the liver. , 1993, EXS.
[43] C. Hulstaert,et al. Heterogeneity of rat liver and spleen macrophages in gadolinium chloride–induced elimination and repopulation , 1992, Journal of leukocyte biology.
[44] S. Korsmeyer,et al. Bcl-2 initiates a new category of oncogenes: regulators of cell death. , 1992, Blood.
[45] S. Akira,et al. A nuclear factor for IL‐6 expression (NF‐IL6) is a member of a C/EBP family. , 1990, The EMBO journal.
[46] H. Esterbauer,et al. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. , 1990, Methods in enzymology.
[47] D. Goeddel,et al. Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism , 1988, Science.
[48] P. M. Rao,et al. Liver tumour promotion by chemicals: models and mechanisms. , 1986, Cancer surveys.
[49] J. Swenberg,et al. Correlation of O4-ethyldeoxythymidine accumulation, hepatic initiation and hepatocellular carcinoma induction in rats continuously administered diethylnitrosamine. , 1986, Carcinogenesis.
[50] G. Klein,et al. Evolution of tumours and the impact of molecular oncology , 1985, Nature.
[51] J. Farber,et al. Mechanisms of cell injury with hepatotoxic chemicals. , 1984, Pharmacological reviews.
[52] S. Sell,et al. An Evaluation of Cellular Lineages in the Pathogenesis of Experimental Hepatocellular Carcinoma , 2007, Hepatology.
[53] J. Taylor,et al. Changes in rat alpha 1-fetoprotein and albumin mRNA levels during fetal and neonatal development. , 1980, The Journal of biological chemistry.
[54] I. M. Neiman,et al. [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.
[55] I. Berenblum. Carcinogenesis and tumor pathogenesis. , 1954, Advances in cancer research.